This articles provides two studies that support the use of botanicals for liver health. Liver disease has been declared a global health issue affecting about 25%. Health issues related to NAFLD alone are projected to cost Americans more than $1 trillion dollars over the next 10 years and result inRead
Echosens, a high-technology company offering the FibroScan family of products, is proud to support the Fatty Liver Foundation (FLF), a non-profit organization dedicated to fighting fatty liver disease and advocating for ongoing screening of undiagnosed nonalcoholic fatty liver disease (NAFLD) and its more severe form nonalcoholic steatohepatitis (NASH). FLF isRead
Fatty liver disease is not limited to the overweight and obese. Lean people also get fatty liver disease. Though as researchers from The Westmead Institute for Medical Research (WIMR) discovered, how fatty liver disease develops in lean people is very different than in others. The discovery will aid in theRead
The annual Digestive Disease Week, sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, and Society for Surgery of the Alimentary Tract, was held from May 18 to 21 in San Diego. Two studies caught the attention of Today’s Practitioner:Read
Preterm and early term birth are strong risk factors for the development of chronic kidney disease (CKD) from childhood into mid-adulthood, suggests a study from Sweden published by The BMJ. Given the high levels of preterm birth (currently 10% in the US and 5-8% in Europe), and better survival intoRead
Researchers have developed a new test that could diagnose early chronic kidney disease in patients with type 2 diabetes. This novel method, published in AACC’s Clinical Chemistry journal, could improve quality of life for diabetic patients by potentially catching chronic kidney disease in time to stop its progression to full-blownRead
Increasing the amount of protein in the diet may reduce the liver’s fat content and lower the risk of diabetes in people with nonalcoholic fatty liver disease (NAFLD). The study is published ahead of print in the American Journal of Physiology – Endocrinology and Metabolism. Nonalcoholic fatty liver disease occursRead
With increasing rates of obesity and diabetes, the associated condition of nonalcoholic fatty liver disease (NAFLD) has become increasingly common, such that it is now the number one cause of liver disease in Western countries.[1] NAFLD affects 10 to 46% of the U.S. population, with a worldwide prevalence of 10Read
Did you know that the average life expectancy for someone on kidney dialysis is five years? If you didn’t, you are not alone. Editor and integrative medicine expert Jeffrey Bland, PhD wrote in a recent opinion column in Integrative Medicine, a Clinician’s Journal he was dismayed to learn this factRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
